[Tertatolol--characteristics of the drug].
R
R
Tomaszewski
J
J
Kliz
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004231:Diuresis / Q000187:drug effects / Q000502:physiology; D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D005919:Glomerular Filtration Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007668:Kidney / Q000098:blood supply / Q000187:drug effects* / Q000502:physiology; D008875:Middle Aged; D008954:Models, Biological; D011412:Propanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D012079:Renal Circulation / Q000187:drug effects / Q000502:physiology; D013876:Thiophenes; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics; D011412:Propanolamines; D013876:Thiophenes; C005632:tertatolol
Tertatolol-charakterystyka leku.